Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
313.26B | 299.60B | 275.06B | 253.39B | 283.75B | 293.68B | Gross Profit |
114.83B | 108.96B | 97.93B | 95.00B | 126.76B | 133.77B | EBIT |
20.50B | 19.47B | 16.63B | 19.23B | 19.40B | 19.00B | EBITDA |
26.04B | 41.08B | 33.47B | 30.21B | 31.14B | 32.28B | Net Income Common Stockholders |
13.39B | 17.58B | 13.67B | 13.96B | 8.75B | 11.46B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
49.72B | 80.76B | 70.75B | 81.01B | 88.42B | 77.32B | Total Assets |
231.93B | 431.60B | 396.73B | 382.02B | 369.15B | 367.19B | Total Debt |
5.45B | 12.33B | 10.65B | 5.86B | 5.41B | 5.41B | Net Debt |
-12.46B | -68.44B | -54.10B | -69.14B | -73.50B | -61.02B | Total Liabilities |
49.30B | 109.99B | 95.39B | 83.45B | 81.86B | 86.27B | Stockholders Equity |
182.28B | 292.21B | 272.29B | 268.97B | 258.14B | 248.77B |
Cash Flow | Free Cash Flow | ||||
0.00 | 12.90B | 4.32B | 2.37B | 12.19B | 8.32B | Operating Cash Flow |
0.00 | 25.57B | 19.48B | 16.14B | 23.18B | 24.22B | Investing Cash Flow |
0.00 | -2.30B | -21.47B | -10.40B | -8.56B | -6.36B | Financing Cash Flow |
0.00 | -7.38B | -12.74B | -10.07B | -6.17B | -7.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥979.61B | 15.31 | 13.14% | 1.74% | 12.15% | 44.46% | |
75 Outperform | ¥460.52B | 16.35 | 9.19% | 1.65% | 5.92% | 56.91% | |
74 Outperform | $1.35T | 21.40 | 12.17% | 1.70% | 7.29% | 9.77% | |
74 Outperform | $3.25T | 46.58 | 8.89% | 1.20% | 8.76% | -0.23% | |
73 Outperform | $277.93B | 21.63 | 4.20% | 1.67% | 6.21% | -25.51% | |
69 Neutral | €497.75B | 20.06 | 9.55% | 2.35% | 3.70% | 0.75% | |
64 Neutral | $8.75B | 14.76 | 4.97% | 174.27% | 3.56% | 3.44% |